| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Nonalcoholic fatty liver disease 0.4898990663017796 2.6646979819934526 0.0077057492988856 0.9904297005779024 0.1421082189690121 49 O14949,P14406,P31751,Q9UDW1,P22695,O43676,O75306,P00403,O96000,Q9P0J0 10 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.6980643748808649 2.6283176539459667 0.0085808345912103 0.9943682497999096 0.1421082189690121 15 P50402,O60725,O75844,P55209,Q13547 5 |
| Electron transport chain oxphos system in mitochondria 0.4755133260642621 2.586689651810743 0.0096902827164313 0.9971266048295482 0.153259471383559 52 P03886,P00846,O14949,P14406,Q9UDW1,P22695,O43676,O75306,P00403,O96000 10 |
| Proteasome degradation 0.4978838486971536 2.480871540409879 0.0131061596359256 0.9996398085046312 0.1921171205168614 42 O00231,Q9UL46,Q99436,P28072,P28070,Q06323,P61289,P04439,P49721,P28074,P10321,P01889,P20618 13 |
| Ferroptosis 0.5611379518124804 2.3794648185952374 0.0173377979469964 0.9999727758058092 0.2280798315611726 24 Q9UKU0,P04035,P09601,P37268,Q15043,Q96QD8,P02786,P45880 8 |
| Allograft rejection 0.7408512471244979 2.360796745606623 0.0182357222319649 0.9999842839725815 0.2331844481151256 10 P08183,P08670,P04439,P10321,Q9BY49 5 |
| Mitochondrial complex iii assembly 0.6574013279459061 2.1311408251633073 0.0330775422742199 0.9999999983389604 0.3442279088196984 12 Q9UDW1,O14949,P22695 3 |
| Ethanol effects on histone modifications 0.687029462937243 2.085576588966693 0.037016993820929 0.9999999998571788 0.3455008685524787 10 O94788,P00374 2 |
| Mitochondrial complex i assembly model oxphos system 0.5058055065140185 2.051262752399012 0.0402413657215865 0.9999999999809728 0.3455008685524787 26 P03886,Q96CU9,O43676,O75306,O96000 5 |
| Influence of laminopathies on wnt signaling 0.6975920955156225 1.9997919902055916 0.0455227298687033 0.9999999999993096 0.3703387542745254 9 P50402,O60725,O75844 3 |
| Alzheimers disease 0.3765033450140693 1.9808456885148156 0.0476085813337792 0.9999999999998146 0.3703387542745254 84 Q9NSK0,P21796,P31751,P28072,Q99436,P25054,P28070,Q9NQC3,Q92542,O14641,P33176,P45880,O95197,P49721,P20618 15 |
| Calcium regulation in cardiac cells 0.5219053683415662 1.9768027432488335 0.048063931503183 0.9999999999998608 0.3703387542745254 22 P31946,Q13555,P61981,P27797,Q04917,P63104,P62942,P23634,P62258,Q14012,P08754,P13861,P10644,P05026,P16615,P0DP25 16 |
| Statin inhibition of cholesterol production 0.9034998301053212 1.931997780022334 0.0533597798845897 0.9999999999999952 0.3910881428126638 5 P37268,P04035,P35610,Q8WTV0 4 |
| Alzheimers disease and mirna effects 0.3708432211239886 1.914731848976337 0.0555267096850689 0.9999999999999988 0.4020668978400772 86 Q9NSK0,P21796,P31751,P28072,Q99436,P25054,P28070,Q9NQC3,Q92542,O14641,P33176,P45880,O95197,P49721,P20618 15 |
| Retinoblastoma gene in cancer 0.4293446557946175 1.907761922330128 0.056421994295033 0.9999999999999992 0.4036859353727959 45 P09455,P16949,Q14566,P00374,Q9Y619,Q13547 6 |
| Endothelin pathways 0.7474027970137593 1.880712148300744 0.0600110862236027 1.0 0.4193798002370377 7 P00403 1 |
| Vitamin a and carotenoid metabolism 0.8869449980640964 1.86498055796935 0.0621841294351472 1.0 0.4233269330373928 5 P09455,Q8WTV0 2 |
| Mitochondrial complex iv assembly 0.5890876647744208 1.8121266406375147 0.0699666308561841 1.0 0.4428287369480561 13 Q9Y2R0,P00403,P14406 3 |
| Glycosaminoglycan degradation 0.779859776281033 1.8082528786437264 0.0705671520852617 1.0 0.4428287369480561 6 P06865,P54802 2 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.4721970194510959 1.695729036501168 0.089937206940142 1.0 0.5099269940662772 24 P04035,Q16850,P37268,Q15800,Q15392,Q9BWD1,P35610 7 |
| Zinc homeostasis 0.8771215207060392 1.6807741114870858 0.0928067989933891 1.0 0.5177569534919872 2 Q8TAD4 1 |
| Striated muscle contraction pathway 0.8384552437162661 1.6667785011905338 0.0955584566622362 1.0 0.5177569534919872 5 P08670,P09493,P06753 3 |
| Proteoglycan biosynthesis 0.8730482009504357 1.6632870628170335 0.0962549871302247 1.0 0.5177569534919872 2 Q8NCH0 1 |
| Congenital generalized lipodystrophy cgl 0.8655804480651667 1.6312012734012706 0.1028478567186952 1.0 0.5210399325866677 2 P31751 1 |
| Ketogenesis and ketolysis 0.8279806330936097 1.623633971058313 0.1044539507509991 1.0 0.521958604992261 5 P23786,P53985,O43772 3 |
| Vitamin d receptor pathway 0.5662636777872739 1.6111609524360508 0.1071446460859499 1.0 0.5278191171939012 12 P08183,P09493,P24941,Q92783,P42771 5 |
| Mevalonate arm of cholesterol biosynthesis pathway 0.5730797205001132 1.5589688310722667 0.1190037575088882 1.0 0.5721700661027347 11 P37268,Q9BWD1,P35610 3 |
| Cellular proteostasis 0.883353323090556 1.476394132381336 0.1398381169759761 1.0 0.6409355469742389 4 O15212,Q9UHV9 2 |
| Ccl18 signaling pathway 0.6145416825840002 1.4590018247868737 0.144564605446702 1.0 0.6409355469742389 8 P00403,P08670,P33176 3 |
| Folate metabolism 0.5300333698263249 1.4574686930391307 0.1449870471845953 1.0 0.6409355469742389 13 Q8WTV0 1 |
| Arachidonate epoxygenase epoxide hydrolase 0.8224711473183907 1.4455434488221444 0.1483052980124628 1.0 0.6458803196050013 2 P20674 1 |
| Myometrial relaxation and contraction pathways 0.4679216793777503 1.3881177333543406 0.1651011974890839 1.0 0.6852562988468762 18 P16220,P31946,Q13555,P61981,Q05682,Q04917,P63104,P62258,P13861,P10644,P78417,P16615,P0DP25 13 |
| Metapathway biotransformation phase i and ii 0.4366874714302692 1.3778021909434324 0.1682643694044368 1.0 0.6852562988468762 23 Q16850,Q7LGA3,P34913,P07099,Q8NCH0,Q6UW02,P00390 7 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.751459781490559 1.3061551401668683 0.1914998046927332 1.0 0.7335547863642824 5 P07099 1 |
| Cholesterol biosynthesis pathway 0.4850267839484414 1.2413060732902756 0.214492701973322 1.0 0.7840814640366551 14 P37268,P04035,Q16850,Q15800 4 |
| 1q211 copy number variation syndrome 0.5473819001555627 1.2219449677544834 0.2217284387748028 1.0 0.7840814640366551 9 Q9NPH0 1 |
| Oxidation by cytochrome p450 0.7311860910404407 1.221790742728958 0.2217867701933966 1.0 0.7840814640366551 5 Q16850,O43169 2 |
| G1 to s cell cycle control 0.4024664209839133 1.1986026604783993 0.2306824832107319 1.0 0.7922295566265707 26 Q14566 1 |
| Familial partial lipodystrophy fpld 0.580833174677463 1.0948988764794936 0.2735609413364159 1.0 0.8751198836817948 7 P31751,O75844 2 |
| Nanomaterial induced apoptosis 0.6159458069716119 1.075395095852618 0.2821978765176238 1.0 0.8751198836817948 6 Q9NR28,O95831 2 |
| Sterol regulatory elementbinding proteins srebp signaling 0.3742148908733634 1.069934118294109 0.2846489644220398 1.0 0.8751198836817948 29 P37268,Q16850,Q8WTV0 3 |
| Oxidative phosphorylation 0.3670937977100322 1.0487328160917562 0.2943011062577412 1.0 0.8751198836817948 30 P03886,P00846,Q86Y39,O75964,O75306,Q15904,O96000 7 |
| Modulators of tcr signaling and t cell activation 0.4916388532309773 1.0269559771828038 0.3044411939349281 1.0 0.8788390034888706 10 O96000 1 |
| Initiation of transcription and translation elongation at the hiv1 ltr 0.6045772984320337 1.0244568250467956 0.3056195536259134 1.0 0.8788390034888706 6 Q13547 1 |
| Aryl hydrocarbon receptor pathway wp2873 0.678026126107023 1.001783703762591 0.3164480695328251 1.0 0.9013520843091368 5 O00170,Q16543 2 |
| Degradation pathway of sphingolipids including diseases 0.5970183887229551 0.9906875832036914 0.321838156006506 1.0 0.9026440976057252 6 P06865,P06280,P17900 3 |
| Dna replication 0.3736459047531912 0.9879617755647684 0.3231713689095032 1.0 0.9026440976057252 27 Q14566 1 |
| Notch signaling 0.5202140346472465 0.9823791514404652 0.3259130934782734 1.0 0.9026440976057252 8 Q92542,Q13547 2 |
| Complement system in neuronal development and plasticity 0.469581723447495 0.967338601732682 0.333374792448323 1.0 0.9102345353879469 11 Q5KU26,Q9NR28,O43464 3 |
| Tnfrelated weak inducer of apoptosis tweak signaling pathway 0.4645007198879588 0.9383246820768416 0.3480775791881039 1.0 0.9256399340356214 11 P31751 1 |
| 15q112 copy number variation syndrome 0.761629881154496 0.8838965718512398 0.3767520479815134 1.0 0.9395351901945626 3 Q9BSJ2,Q06787 2 |
| Translation factors 0.3418950198642375 0.8678384409680194 0.3854827826382423 1.0 0.9489911926426132 37 O75153,P49770,P23588,Q15056,P55010,P29692 6 |
| Overview of nanoparticle effects 0.7555178268251022 0.8616738317386967 0.3888670295704606 1.0 0.950036929966857 3 Q05397,P09601 2 |
| Neural crest differentiation 0.4755216933780123 0.843664312788462 0.3988570149963704 1.0 0.953461585189049 9 Q13547 1 |
| Male infertility 0.390245899407526 0.8311886347829157 0.4058670742233483 1.0 0.9565729866989504 18 Q15165,P17096,P08183,P10909 4 |
| Regulation of wnt bcatenin signaling by small molecule compounds 0.6311869129112346 0.8118548227854248 0.4168749400071958 1.0 0.963622457478172 5 O14641,P25054 2 |
| Sarscov2 and covid19 pathway 0.7386398054112594 0.8008899019187157 0.423195386585272 1.0 0.9675366084697788 3 Q8WTV0 1 |
| Acquired partial lipodystrophy barraquersimons syndrome 0.7044836956521868 0.7944856569078826 0.4269127556691039 1.0 0.9675366084697788 4 O60725,P02545,Q03252 3 |
| Mitochondrial long chain fatty acid betaoxidation 0.4130765382990882 0.7867174733743985 0.4314472729948431 1.0 0.9675366084697788 14 P23786,O43772 2 |
| Endometrial cancer 0.4193121607927855 0.7801033315673641 0.435330055622571 1.0 0.9726147339374168 13 P25054,P31751 2 |
| Mevalonate pathway 0.545614378142444 0.7646021788656466 0.4445084713184684 1.0 0.9796284485280852 6 P04035,Q9BWD1 2 |
| Mecp2 and associated rett syndrome 0.3756698462765599 0.752781551526233 0.4515811945598291 1.0 0.983334412791512 19 P52597,P35637,Q13547,Q13451,P67809 5 |
| Proximal tubule transport 0.4564351739490014 0.7452647533279235 0.4561116843190818 1.0 0.9883129175218688 9 Q9Y5K8,P08183 2 |
| Nucleotidebinding oligomerization domain nod pathway 0.461032596043139 0.6896775980453244 0.490396956659707 1.0 1.0 8 Q9P0J0 1 |
| Adipogenesis 0.4008407558296698 0.669886966142637 0.502929849095533 1.0 1.0 13 P17096,O75844 2 |
| Transcription cofactors ski and skil protein partners 0.665029594404683 0.6532265330919156 0.5136102471834649 1.0 1.0 4 Q13547 1 |
| Notch signaling pathway 0.4106815502489157 0.6368960475447214 0.5241925574581656 1.0 1.0 11 Q96T58,Q13547 2 |
| Physicochemical features and toxicityassociated pathways 0.3612019383271028 0.6275522844171172 0.5302972750083699 1.0 1.0 18 Q05397,Q14012,P62993,P25054 4 |
| Nephrotic syndrome 0.3925610198844316 0.6212723710608902 0.5344204291998085 1.0 1.0 13 Q14108,O75844 2 |
| Dna damage response only atm dependent 0.3531204391761215 0.616464934768285 0.5375877079954416 1.0 1.0 20 P25054,O14641,P31751,P62993,P09429,P42771 6 |
| Embryonic stem cell pluripotency pathways 0.3857332208025989 0.5816387686034435 0.5608100235141062 1.0 1.0 13 P25054,P62993,P31751 3 |
| Camkk2 pathway 0.38694627307157 0.557255628784207 0.5773527869963093 1.0 1.0 12 P09601 1 |
| Cholesterol biosynthesis with skeletal dysplasias 0.4959312388333428 0.5567676579039406 0.5776861838014433 1.0 1.0 6 Q16850,Q15392,Q14739 3 |
| Glycosylation and related congenital defects 0.4317834676748222 0.5517013664661585 0.5811529736055392 1.0 1.0 8 P34949 1 |
| Amyotrophic lateral sclerosis als 0.4173413287404552 0.5503204107663967 0.5820996271366954 1.0 1.0 9 Q16539,P07197,Q9BUN8 3 |
| Wnt signaling pathway and pluripotency 0.3778201619045174 0.5362968874561364 0.5917533814138338 1.0 1.0 13 P30154,P25054 2 |
| Head and neck squamous cell carcinoma 0.3733116528985299 0.5107794466697217 0.6095055026953513 1.0 1.0 13 P62942 1 |
| Oxidative stress response 0.5431611021043149 0.4794500891439828 0.6316184670180502 1.0 1.0 5 P09601,P00390 2 |
| Transcription factors regulate mirnas related to cardiac hypertrophy 0.6274213865906343 0.4335023025234962 0.6646498936928398 1.0 1.0 3 P31751 1 |
| Spinal cord injury 0.3285606893092148 0.4256371756122384 0.6703722469976063 1.0 1.0 19 P08670,P62942,Q9NQC3 3 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.5242283968215495 0.4149227897151902 0.6781984259656049 1.0 1.0 5 Q9BXK5,P49840 2 |
| Thermogenesis 0.3004273057661183 0.3998692769962487 0.6892528020542603 1.0 1.0 28 Q9UKU0,Q969G3,P62993,Q8TAQ2,Q96B36,P54619,P23786,O43772 8 |
| T cell receptor and costimulatory signaling 0.5868161370347031 0.3987944496194389 0.690044667104611 1.0 1.0 4 P49840 1 |
| Ciliary landscape 0.2604483967022396 0.3635696816556205 0.71617937009295 1.0 1.0 95 Q9BT78,Q14566,P25054,O15173,P10619,O43464,A0AVF1,P08579,P08670,O60343,P07197,Q99627,Q13547,O43805,Q9Y266 15 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.3480756405503313 0.3513633454598881 0.7253157775922698 1.0 1.0 12 O75718,Q32P28 2 |
| Nsp1 from sarscov2 inhibits translation initiation in the host cell 0.338128901407699 0.3217685482635575 0.7476280429883091 1.0 1.0 13 O75822,P55010 2 |
| Hedgehog signaling pathway wp4249 0.5736540993666926 0.2881660472280986 0.7732196372933635 1.0 1.0 3 Q9UMX1 1 |
| Neural crest cell migration in cancer 0.3587170084012324 0.2877646754247481 0.7735268790149994 1.0 1.0 9 P31751 1 |
| Nanoparticlemediated activation of receptor signaling 0.3935155100748827 0.2798923376338612 0.7795601060554229 1.0 1.0 7 Q05397,P62993 2 |
| Apoptosis modulation and signaling 0.3037134531854539 0.2579565521763261 0.7964404389834154 1.0 1.0 18 Q9NR28,O95831 2 |
| Relationship between inflammation cox2 and egfr 0.5335980634950911 0.2548350212769731 0.798850524962107 1.0 1.0 4 P31751 1 |
| Target of rapamycin tor signaling 0.3327144357164225 0.2269671857229812 0.8204492583180489 1.0 1.0 10 P04035,Q96B36,P62942 3 |
| Il6 signaling pathway 0.3276574367016837 0.2070476650160605 0.8359726336347102 1.0 1.0 10 Q13547 1 |
| Aryl hydrocarbon receptor pathway wp2586 0.3469599065243087 0.2061514200153575 0.8366726339207791 1.0 1.0 8 O00170,Q16543 2 |
| Complement and coagulation cascades 0.5334866415131938 0.1989858394470355 0.8422738215799317 1.0 1.0 3 P10909 1 |
| Progeriaassociated lipodystrophy 0.3351670385725476 0.1979326349647249 0.8430977702645743 1.0 1.0 9 O75844 1 |
| Breast cancer pathway 0.2842737107629803 0.1921474964896287 0.8476266711937768 1.0 1.0 22 P25054,P62993,P31751 3 |
| Translation inhibitors in chronically activated pdgfra cells 0.292564280862156 0.1888429226056135 0.8502159296664018 1.0 1.0 17 P31751 1 |
| Glucocorticoid receptor pathway 0.3831834289724891 0.1725213933612115 0.8630276440398252 1.0 1.0 6 P27105,Q99576 2 |
| Insulin signaling in adipocytes normal condition 0.4744505902773185 0.1321406987094397 0.8948730052273866 1.0 1.0 4 P31751 1 |
| Insulin signaling in adipocytes diabetic condition 0.4744505902773185 0.1321406987094397 0.8948730052273866 1.0 1.0 4 P31751 1 |
| Wntbetacatenin signaling pathway in leukemia 0.4197072894387758 0.1320824188632584 0.8949191017841793 1.0 1.0 5 P25054 1 |
| Angiogenesis 0.4733518335296646 0.1302694165008361 0.8963532759464616 1.0 1.0 4 Q05397 1 |
| Reninangiotensinaldosterone system raas 0.4159377275369955 0.124674409804985 0.9007813173199576 1.0 1.0 5 P0DP25,Q14012,Q13555 3 |
| 7oxoc and 7betahc pathways 0.3113101036942015 0.1190094379237989 0.9052678785429152 1.0 1.0 9 P61916,O15118 2 |
| Kennedy pathway from sphingolipids 0.4825127334465234 0.1128043569543598 0.9101856640442036 1.0 1.0 3 O95470,P48651 2 |
| Tnfalpha signaling pathway 0.2721142471506382 0.1016309778429031 0.9190495899878584 1.0 1.0 20 Q9NR28,P62993,Q16543 3 |
| Type 2 papillary renal cell carcinoma 0.3090940664102586 0.0930089019805705 0.9258964891232282 1.0 1.0 8 Q92733 1 |
| Egfegfr signaling pathway 0.2540727468763513 0.0915094268543313 0.9270878161195456 1.0 1.0 38 P16949,P00403,Q05397,Q9P0J0,Q92783 5 |
| Nonsmall cell lung cancer 0.2790787989612067 0.0731125639096015 0.9417165438630362 1.0 1.0 14 P62993,P31751 2 |
| Small cell lung cancer 0.2852051411648979 0.0708087815279967 0.9435499427218328 1.0 1.0 11 Q05397,Q07812,P31751 3 |
| Gdnfret signaling axis 0.4468590831918545 0.0705247927924435 0.9437759678818164 1.0 1.0 3 O94813,Q9BW83 2 |
| Hostpathogen interaction of human coronaviruses interferon induction 0.3772521692799355 0.0608893719097768 0.9514473137286537 1.0 1.0 5 Q13546,Q16539 2 |
| Type i interferon induction and signaling during sarscov2 infection 0.3679565512559357 0.0484362036997645 0.9613686067729212 1.0 1.0 2 P42224 1 |
| Genes related to primary cilium development based on crispr 0.2716966493567119 0.0315483294252848 0.9748322499997332 1.0 1.0 11 A0AVF1,O95684 2 |
| Preimplantation embryo 0.2961850775322511 0.0295636016993897 0.976415094252698 1.0 1.0 7 P17096 1 |
| White fat cell differentiation 0.3840407470288646 0.0270144838535709 0.9784481818031 1.0 1.0 3 P16220,P35221 2 |
| Methylation pathways 0.3358234295415973 0.0127940784328041 0.9897920808359232 1.0 1.0 3 P21964,Q9NZL9 2 |
| Airway smooth muscle cell contraction 0.3299354400271881 0.0114620646785122 0.9908547958063816 1.0 1.0 5 Q13464,O75116,P61586,P62140 4 |
| Cannabinoid receptor signaling 0.3436781134964204 0.0060229919558452 0.995194376763753 1.0 1.0 4 P10644 1 |
| Vitamin b12 disorders 0.3376358695652161 0.0039618999708978 0.996838869451638 1.0 1.0 4 Q99707,Q9NPF0,Q96EY8 3 |
|
|
